Standout Papers

Overall Survival and Updated Results for Sunitinib Compared... 1999 2026 2008 2017 1.7k
  1. Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma (2009)
    Robert J. Motzer, Thomas E. Hutson et al. Journal of Clinical Oncology
  2. Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group (2008)
    Howard I. Scher, Susan Halabi et al. Journal of Clinical Oncology
  3. Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma (2005)
    Robert J. Motzer, M. Dror Michaelson et al. Journal of Clinical Oncology
  4. Sunitinib in Patients With Metastatic Renal Cell Carcinoma (2006)
    Robert J. Motzer, Brian I. Rini et al. JAMA
  5. Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate Cancer (1999)
    Edward M. Messing, Judith Manola et al. New England Journal of Medicine
  6. Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate Cancer (1998)
    Mario A. Eisenberger, Brent A. Blumenstein et al. New England Journal of Medicine
  7. Therapy-Induced Senescence in Cancer (2010)
    Jonathan A. Ewald, Joshua A. Desotelle et al. JNCI Journal of the National Cancer Institute
  8. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy (2006)
    Edward M. Messing, Judith Manola et al. The Lancet Oncology

Immediate Impact

5 by Nobel laureates 5 from Science/Nature 111 standout
Sub-graph 1 of 13

Citing Papers

Renal cell carcinoma
2024 Standout
Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
2021 Standout

Works of George Wilding being referenced

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
2023
Phase II trial of gemcitabine and docetaxel in patients with advanced carcinoma of the urothelium
2003
and 1 more

Author Peers

Author Last Decade Papers Cites
George Wilding 11923 6748 9776 308 21.9k
Christopher J. Logothetis 9469 7820 6778 448 20.4k
Tomasz M. Beer 10570 5989 4244 402 17.4k
Walter M. Stadler 13822 9239 11753 466 26.3k
Yoshitaka Fujii 8943 8242 7574 436 19.6k
Alex A. Adjei 8009 11339 12744 467 25.6k
Giampaolo Tortora 7644 13500 9748 619 23.7k
Martin Gleave 15695 8915 15487 679 32.0k
David S. Hong 6145 10195 9319 810 22.5k
Kim N. 19731 8367 6565 359 25.2k
Waun Ki Hong 7980 12563 16651 505 33.5k

All Works

Loading papers...

Rankless by CCL
2026